Browsing Medications's Archives »»

Now Treat Male Pattern Hair loss Efficiently with Propecia?

Propecia: An Introduction

Propecia is prescribed to effectively deal with the dilemma of male pattern hair loss about the places such as anterior mid scalp and vertex. Propecia pills contain the crucial ingredient finesteride, which is also recognized as five-alpha reductase inhibitor. You need to be curious to know ‘how Propecia functions’. Propecia (finesteride) restricts the working of five-alpha reductase, hence lowering the release of DHT or dihydrotestosterone. DHT brings about hair loss by rupturing hair follicles. This is particularly noticed far a lot more in males genetically sensitive to it. Propecia lowers the quantity of DHT in scalp and blood to a significant extent, thereby improving hair improvement. Propecia need to be taken orally by men and women struggling with male pattern hair loss to speed up hair improvement and also to inhibit further hair loss. Propecia aids to enhance hair density and decrease hair loss within 3-six months of therapy, contingent upon adhering to the doctor’s ideas.

The manufacturers of Proscar Finasteride 5mg found in 1992 that the medicine made by them to treat and lessen men’s prostate situations such as benign prostatic hyperplasia, was expanding back hair on some of the patient’s heads who had been bald hitherto. A couple of years of analysis later resulted in Propecia Finasteride 1mg which was dedicated to cure alopecia, or hair loss, in guys. FDA place its seal of approval on the drug in 1997.

How to Use Propecia

Never take Propecia without having talking to the physician. The crucial for rapid outcomes is employing the medicine as per the suggestions offered by the doctor. It also assists to hold the side effects, if any, at bay. Take Propecia with a glass of drinking water without having or with food nonetheless, be positive that you take it the identical time every single day. Normally, the dosage approved is 1 tablet per day for a time period of 3 months to obtain the very best outcome. If you discontinue employing the medication in the middle of the course, hair loss will relapse within a 12 month period of discontinuing the treatment. To make certain the therapy is delivering the anticipated outcome, your medical professional will recommend periodic blood tests to be completed. It is really essential to not consume a double dose of this medication for catching up on the missed dose.

Precautions and Notes

Read the following notes and precautions prior to taking Propecia.

– Shop this medicine at a place that can’t be accessed by pregnant girls. If a pregnant lady handles damaged or crushed pills, it may possibly possibly spark off some dangers at the time of delivery. Propecia tablets are coated to stop direct get in touch with with the major ingredient.

– Propecia may possibly make you dizzy. Get up slowly if you’re lying or resting. Arising rapidly from lying or resting position could make you really feel giddy.

For much more information about Propecia Generic Finasteride, talk to your Medical doctor

Drug-Induced ED Part 3

Lipid Lowering Medication

Fibrates (clofibrate, gemfibrozil, and less frequently bezafibrate and fenofibrate) are lipid-lowering medications that have long been associated with medication-induced sexual dysfunction.

A case­control study of 339 age­matched men revealed that there were more impotent men in the group of patients treated with lipid-lowering medications (12% vs. 5.6%); and multivariate anal-ysis showed that fibrates and statins were independent risk factors for erectile dysfunction.

A contemporary systematic review was recently carried out by a group in England evaluating the evidence associating lipid lowering therapies, including statins, with the onset of ED. While there are multiple trials that do not show and increased rate of sexual dysfunction in patients taking lipid lowering medications versus placebo, the authors report several studies in which the initiation of clofibrate, gemfibrozil, and multiple statins was associated with ED. While it remains unclear what the true rates of sexual adverse events with hypolipidemics, the mechanism in which this occurs is thought to be through decreased synthesis of sex steroid hormones derived from cholesterol, namely, testosterone. In addition to their known effects on serum lipid levels, statins have been hypothesized to mediate anti-inflammatory effects through several different pathways, including the inhibition of NOS activity. Thus, it is possible that statins might potentiate erectile dysfunction via decreased nitric oxide levels.

Miscellaneous and Kamagra Australia

Case reports of sexual side effects from metoclopramide, baclofen, amicar (epsilon-amino-car-poic acid), disulfiram, and carbonic anhydrase inhibitors have been associated with ED. Cytotoxic drugs have also been implicated in drug­related ED include methotrexate and thalidomide. Digoxin is yet another drug that has been suggested to induce ED. The mechanism it thought to be via blockade of the Na+, K+­ATPase pump, resulting in a net increase in intracellular calcium and increased corporal smooth muscle tone. Others have also suggested that the chemical structure of digoxin is similar to sex steroids leading to antiandrogen activity.

Immunomodulators

Decreased libido and ED are commonly reported side effects experienced by male patients during antiviral therapy for chronic hepatitis C. This effect was studied in 34 male patients being treated with interferon and ribavirin. Free and total testosterone decreased significantly during antiviral therapy while depression scores increased during therapy.

Certain agents used in renal transplantation have been implicated in erectile function as well. The immunosuppressive agents’ target of rapamycin inhibitors (i.e., sirolimus and everolimus) have been shown to result in decreases in serum testosterone levels, increases in levels of luteinizing hormone, and a disruption of spermatogenesis. The impairment of gonadal function is reported to elicit ED in patients receiving these drugs.

Drug-Induced ED Part 2

Hormonal Agents

Androgens are known to increase libido, but their exact role in erectile function remains unclear. Normal levels of testosterone appear to be important for erectile function, particularly in older males. It has been shown that androgen replacement therapy can improve depressed erectile function when ED is secondary to hypogonadism. As such, it is not surprising that any drug that interferes with testosterone production or action might lead to sexual dysfunction. Estrogens, GnRH agonists, LHRH agonists, and corticosteroids can cause ED by suppressing gonadotropin production. Certain drugs like spironolactone, cypoterone acetate, ketoconazole, aminoglutethimide, and other similar drugs have also been shown to have antiandrogen activity and have each been linked to drug-induced sexual dysfunction. These agents often resemble the molecular structure of testosterone and compete with native testosterone for binding to androgen receptors; they have also been shown to induce hyperprolactinemia. Multiple reports have linked H2 blockers to sexual dysfunction. Ranitidine and cimetidine have both been shown to increase prolactin levels and act as antiandrogens.

5a (alpha)-reductase inhibitors

The potential sexual side effects, including ED, decreased libido and ejaculatory problems, which have been reported with 5a-reductase inhibitors (dutasteride and finasteride) are of particular relevance to the urology patient. These drugs block the con-version of testosterone to the more potent androgen, dihydrotestosterone (DHT). Animal models have demonstrated decreased NOS activity with decreased DHT, and thus, it has been proposed that 5a-reductase inhibitors elicit sexual dysfunction by indirectly attenuating NOS activity. Sexual adverse events have been reported in clinical trials at rates of 2.1–38%. The most common complaint is ED, followed by ejaculatory dysfunction and decreased libido. It appears that these effects occur early in the initiation of therapy and decrease over time. The results of these studies, however, have been questioned as the high incidence of drug-induced sexual dysfunction reported in some clinical tri-als does not seem to correlate with clinician experience. In a more recent study, two groups of blinded, randomized patients received 5 mg of finasteride with and without counseling regarding the potential for sexual side effects. The incidence of ED, decreased libido and ejaculatory problems were significantly reduced in patients who did not receive sexual side effect counseling. The authors conclude that a “nocebo” effect, an adverse effect that is not a direct result of the specific pharmacological action of the drug, should be taken into account when managing patients with reported sexual side effects. This latter study elucidates a common problem encountered by any physician attempting to counsel their patients regarding the potential side effects caused by the drugs mentioned in this chapter. This psychological priming can be a particularly difficult challenge in the management of sexual dysfunction in the setting of drug use.

HIV therapy

HIV and the polypharmacy standardin the care of HIV patients have been associated with sexual dysfunction. A recent cross­sectional study of HIV patients in England estimated the prevalence of moderate to severe ED to be 33% and moderate to severe impairment of sexual desire to be 24%. While multivariate analysis found sexual dysfunction to be common in both patients receiving antiretroviral therapy and those naïve to the drugs, ED was found to be associated with long duration of HIV therapy. A survey among a different group of HIV patients from ten different European countries demonstrated decreased libido and potency in men receiving drug regimens containing protease inhibitors as compared to protease inhibitor naïve patients, specifically identifying protease inhibitors as a drug leading to sexual dysfunction among HIV patients. Studies have shown that antiretroviral therapy is associated with increased aromatization of testosterone leading to increases serum levels of estradiol in men. It is hypothesized that the sexual dysfunction reported by patients taking antiretrovirals is secondary to these hormonal imbalances. Various hormonal replacement strategies have recently been under investigation. While testosterone has been well studied in the treatment of HIV-related wasting syndromes several more recent reports specifically address sexual function. Letrozole, an aromatase inhibitor, and both parenteral and topical forms of testosterone have both been shown not only to increase serum levels of testosterone, but also to improve patient reported sexual function.